EUVIMEDEUVIMED entdecken
Crossref

Peak uptake value on positron emission mammography addresses biopsy sampling limitations in stratifying proliferative activity of malignant non-mass enhancement

Nourhan Emad iD, Aalaa Sobhi, Rasha Wessam, Eman Faker Kamal, Abdel Rahman Omar, Reham Refaie, Dalia Elmesidy

British Journal of Radiology · 2026

DOI: 10.1093/bjr/tqag188 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Radiology, 2026. Verfasst von Nourhan Emad und 6 weiteren Autor:innen. Beteiligte Einrichtung: Radiology Department, Baheya Foundation for Early Detection & Treatment of Breast Cancer, Giza, 12588, Egypt. Hauptthemen laut MEDLINE: Breast Neoplasms, Positron-Emission Tomography, Mammography. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate peak uptake value (PUVmax) derived from positron emission mammography (PEM) as a functional biomarker for identifying high-risk/high-proliferation phenotypes and addressing biopsy sampling limitations in malignant non-mass enhancement (NME).

Methods

This prospective study included patients with MRI-detected Breast Imaging Reporting and Data System (BI-RADS) 4-5 NME between March 2023 and March 2025. Of 246 patients assessed, 92 were excluded because of benign pathology, planned neoadjuvant therapy, incomplete histopathological data, or unavailable surgical outcomes, leaving 154 patients with histologically confirmed malignancy and surgical pathology. All underwent ultrasound-guided core-needle biopsy followed by surgical excision. PEM was performed before biopsy (n = 91) or at least 2 weeks afterward (n = 63). PUVmax was measured, with ≥4.1 defining a high-risk biological phenotype. Interobserver agreement was assessed using the intraclass correlation coefficient (ICC). Receiver operating characteristic curve, multivariable logistic regression, and reclassification analyses were performed.

Results

Interobserver agreement was excellent (ICC = 0.94). Biopsy-surgical discordance occurred in 26/154 cases (16.9%), mainly upgrades (24/26). PEM identified 20/24 upgrades (83.3%). Concordance between PEM and surgical pathology was 97.4%, with 4 false-negative cases (2.6%) and no false positives. PUVmax was significantly associated with high-risk/high-proliferation phenotype (odds ratio = 2.89, 95% CI, 1.95-4.28; P < .001; AUC = 0.86).

Conclusion

PEM-derived PUVmax shows high concordance with surgical pathology and may provide a reliable whole-lesion functional biomarker of high-risk biology in malignant NME. Advances in knowledge A PUVmax threshold ≥4.1 distinguished low- from high-risk disease across invasive carcinoma and ductal carcinoma in situ. PEM correctly reclassified 84.6% of biopsy-surgical discordant cases, potentially reducing underestimation caused by limited biopsy sampling of biologically heterogeneous lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPositron-Emission TomographyMammographyHumansFemaleProspective StudiesMiddle AgedAgedAdultBiopsy, Large-Core NeedleCell Proliferation

Stichwörter der Autor:innen

DCISKi-67breast cancernon-mass enhancementpositron emission mammographytumor heterogeneitytumor proliferation

Autor:innen und Institutionen

  • Radiology Department, Baheya Foundation for Early Detection & Treatment of Breast Cancer, Giza, 12588, Egypt.
  • Radiology Department, Al-Kasr Al-Ainy Teaching Hospital, Cairo University, Cairo, 11562, Egypt.
  • Radiology Department, Saudi German Hospital, Cairo, 11843, Egypt.

ORCID-Profile: Nourhan Emad

Zitieren

APA

Emad, N., Sobhi, A., Wessam, R., Kamal, E. F., Omar, A. R., Refaie, R., & Elmesidy, D. (2026). Peak uptake value on positron emission mammography addresses biopsy sampling limitations in stratifying proliferative activity of malignant non-mass enhancement. British Journal of Radiology. https://doi.org/10.1093/bjr/tqag188

Vancouver

Emad N, Sobhi A, Wessam R, Kamal EF, Omar AR, Refaie R, et al. Peak uptake value on positron emission mammography addresses biopsy sampling limitations in stratifying proliferative activity of malignant non-mass enhancement. British Journal of Radiology. 2026. doi:10.1093/bjr/tqag188

BibTeX
@article{Emad2026,
  author = {Emad, Nourhan and Sobhi, Aalaa and Wessam, Rasha and Kamal, Eman Faker and Omar, Abdel Rahman and Refaie, Reham and Elmesidy, Dalia},
  title = {Peak uptake value on positron emission mammography addresses biopsy sampling limitations in stratifying proliferative activity of malignant non-mass enhancement},
  journal = {British Journal of Radiology},
  year = {2026},
  doi = {10.1093/bjr/tqag188}
}
Kostenlos starten →